CD274 and cancer: Moreover, DUBs-IN-2 treatment upregulated the PD-L1 protein level in a dose-dependent manner in multiple cancer cell lines, but did not affect expression levels of other immune checkpoints we examined (Fig. 1b–g and Supplementary Fig. 1b–g).